Dianthus Therapeutics | MGTA - Interest Income


Dianthus Therapeutics reported $3.66M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Celltrion KRW 621.35M 55.31M Dec/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
IQVIA Holdings USD 10M 1000K Mar/2026
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Moderna USD 70M 3M Dec/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Revvity USD 5.75M 5.75M Dec/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026